Unknown

Dataset Information

0

IL-33 in COVID-19: friend or foe?

ABSTRACT:

SUBMITTER: Liang Y 

PROVIDER: S-EPMC8108013 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

IL-33 in COVID-19: friend or foe?

Liang Yuejin Y   Ge Yiyue Y   Sun Jiaren J  

Cellular & molecular immunology 20210510 6

Similar Datasets

Unknown Interleukin-33: Friend or Foe in Gastrointestinal Tract Cancers?
| S-EPMC10252908 | biostudies-literature
Unknown The complement system in COVID-19: friend and foe?
| S-EPMC7455060 | biostudies-literature
Unknown SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?
| S-EPMC7836403 | biostudies-literature
Unknown Vitamin D supplementation in COVID-19: A friend or foe?
| S-EPMC7573171 | biostudies-literature
Unknown Glucagon-like peptide-1 receptor agonists in the era of COVID-19: Friend or foe?
| S-EPMC7995087 | biostudies-literature
Unknown Emerging Effects of IL-33 on COVID-19.
| S-EPMC9658128 | biostudies-literature
Unknown Microglia: Friend and foe in tauopathy.
| S-EPMC9378545 | biostudies-literature
Unknown Jun, an Oncological Foe or Friend?
| S-EPMC11766113 | biostudies-literature
Unknown PGC1α: Friend or Foe in Cancer?
| S-EPMC5793199 | biostudies-literature
Unknown Exercise during chemotherapy: Friend or foe?
| S-EPMC10225227 | biostudies-literature